Clinical Trial Update: Evaluation of Afatinib in Maintenance Therapy in Squamous Cell Carcinoma of the Head and Neck [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating afatinib as maintenance therapy for head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: Centre Leon Berard | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 3 | Status: COMPLETED